0.0951 USD
-1.69 (-94.69%)
At close: Oct 30, 2025
0.12 USD
+0.02 (+26.18%)
After Hours: 10/30/2025, 8:00:00 PM
Overall CERO gets a fundamental rating of 0 out of 10. We evaluated CERO against 525 industry peers in the Biotechnology industry. CERO has a bad profitability rating. Also its financial health evaluation is rather negative. CERO does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- CERO had negative earnings in the past year.
- In the past year CERO has reported a negative cash flow from operations.
1.2 Ratios
- With a Return On Assets value of -675.76%, CERO is not doing good in the industry: 97.20% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -675.76% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-69.95%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CERO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CERO has more shares outstanding than it did 1 year ago.
- There is no outstanding debt for CERO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -27.63, we must say that CERO is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -27.63, CERO is not doing good in the industry: 87.87% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -27.63 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CERO has a Current Ratio of 0.56. This is a bad value and indicates that CERO is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.56, CERO is not doing good in the industry: 92.35% of the companies in the same industry are doing better.
- A Quick Ratio of 0.56 indicates that CERO may have some problems paying its short term obligations.
- CERO has a Quick ratio of 0.56. This is amonst the worse of the industry: CERO underperforms 91.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
- CERO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.38%, which is quite impressive.
EPS 1Y (TTM)63.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- CERO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.78% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y90.59%
EPS Next 2Y39.36%
EPS Next 3Y24.78%
EPS Next 5Y14.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CERO. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CERO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CERO's earnings are expected to grow with 24.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.36%
EPS Next 3Y24.78%
5. Dividend
5.1 Amount
- No dividends for CERO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CERO THERAPEUTICS HOLDINGS I / CERO FAQ
What is the fundamental rating for CERO stock?
ChartMill assigns a fundamental rating of 0 / 10 to CERO.
Can you provide the valuation status for CERO THERAPEUTICS HOLDINGS I?
ChartMill assigns a valuation rating of 1 / 10 to CERO THERAPEUTICS HOLDINGS I (CERO). This can be considered as Overvalued.
Can you provide the profitability details for CERO THERAPEUTICS HOLDINGS I?
CERO THERAPEUTICS HOLDINGS I (CERO) has a profitability rating of 0 / 10.